Higher levels and larger increase in circulating pro-inflammatory cytokines (VEGF, HGF) with increased expression of pro-inflammatory factors HIF-1α, CREB, and EP300 in DM compared to non-DM groups. This evidence concerns the gene CREB1 and diabetes mellitus.